We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Phathom Pharmaceuticals Inc | NASDAQ:PHAT | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
3.71 | 14.81 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 682k | -201.59M | -3.4474 | -2.69 | 541.5M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | 0 | 9.26 | USD |
Date | Time | Source | Headline |
---|---|---|---|
01/11/2023 | 21:50 | DJN | Phathom Pharmaceuticals Gets FDA Approval for Voquezna Treatment |
12/6/2023 | 14:04 | DJN | FDA Accepts Phathom Pharmaceuticals' Resubmission for Vonoprazan |
Phathom Pharmaceuticals (PHAT) Share Charts1 Year Phathom Pharmaceuticals Chart |
|
1 Month Phathom Pharmaceuticals Chart |
Intraday Phathom Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions